$COLL #Stocks #StockMarket #CollegiumPharmaceutical reported Q4 EPS on https://t.co/savSNU1XbB: COLL announced EPS per share of $-0.07 and Sales of $73 MM in the Q4, Company's losses widen per share, versus $0.27 eps, earned in the same quarter a year… https://t.co/sVaEzd6kym